Pfizer and BioNTech Submit Data Backing Vaccine for Children 5 to 11 by BY SHARON LAFRANIERE, SHASHANK BENGALI AND NOAH WEILAND


The companies said that their vaccine was safe and effective in that age group, and that they would submit a formal request in the coming weeks to U.S. regulators to allow a pediatric dose.

Published: September 29, 2021 at 12:24AM

from NYT Health https://ift.tt/3m9YwDo